304 related articles for article (PubMed ID: 37799149)
1. A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study.
Li JX; Liao PL; Wei JC; Hsu SB; Yeh CJ
Front Public Health; 2023; 11():1143650. PubMed ID: 37799149
[TBL] [Abstract][Full Text] [Related]
2. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
3. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
[TBL] [Abstract][Full Text] [Related]
5. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
6. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.
Sadeghi F; Halaji M; Shirafkan H; Pournajaf A; Ghorbani H; Babazadeh S; Ezami N; Fallhpour K; Fakhraie F; Gorjinejad S; Amoli SS; Amiri FH; Baghershiroodi M; Ahmadnia Z; Salehi M; Tourani M; Jafarzadeh J; Tabari FS; Ahmadian SR; Mohammadi Abandansari R; Jafarian F; Rouhi S; Zabihollahi A; Mostafanezhad S; Saeedi F; Ebrahimian A; Deldar Z; Zavareh MSH; Bayani M; Broun MB; Shirzad M; Sabbaghi S; Mohammadi M; Rahmani R; Yahyapour Y
BMC Infect Dis; 2024 Jan; 24(1):55. PubMed ID: 38184533
[TBL] [Abstract][Full Text] [Related]
7. The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.
Kim K; Cho K; Song J; Rahmati M; Koyanagi A; Lee SW; Yon DK; Il Shin J; Smith L
J Med Virol; 2023 Feb; 95(2):e28522. PubMed ID: 36691933
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes.
Ambrose N; Amin A; Anderson B; Barrera-Oro J; Bertagnolli M; Campion F; Chow D; Danan R; D'Arinzo L; Drews A; Erlandson K; Fitzgerald K; Garcia M; Gaspar FW; Gong C; Hanna G; Jones S; Lopansri B; Musser J; O'Horo J; Piantadosi S; Pritt B; Razonable RR; Roberts S; Sandmeyer S; Stein D; Vahidy F; Webb B; Yttri J
JAMA Netw Open; 2023 Apr; 6(4):e239694. PubMed ID: 37093599
[TBL] [Abstract][Full Text] [Related]
9. Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods - United States, April 2020-June 2022.
Adjei S; Hong K; Molinari NM; Bull-Otterson L; Ajani UA; Gundlapalli AV; Harris AM; Hsu J; Kadri SS; Starnes J; Yeoman K; Boehmer TK
MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(37):1182-1189. PubMed ID: 36107788
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants.
Gunadi ; Hakim MS; Wibawa H; Vujira KA; Puspitarani DA; Supriyati E; Trisnawati I; Iskandar K; Khair RE; Afiahayati ; Siswanto ; Puspadewi Y; Irianingsih SH; Nugrahaningsih DAA; Eryvinka LS; Utami FDT; Devana EM; Aditama L; Kinasih NCP; Hediningsih Y; Ananda NR; Marcellus ; Arguni E; Nuryastuti T; Wibawa T
BMC Med Genomics; 2023 Aug; 16(1):205. PubMed ID: 37644458
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the Omicron variant on cumulative incidence of infection and lethality during the sixth wave of the COVID-19 epidemic in Spain].
Serrano-Cumplido A; Ruíz-García A; Del Rio-Herrero A; Antón-Eguía PB; Micó-Pérez RM; Calderón-Montero A; Romero-Rodríguez E; Segura-Fragoso A; Martín-Sánchez V
Semergen; 2024 Mar; 50(2):102073. PubMed ID: 37839336
[TBL] [Abstract][Full Text] [Related]
12. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
[TBL] [Abstract][Full Text] [Related]
13. Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.
Papagoras C; Zioga N; Papadopoulos V; Gerolymatou N; Kalavri E; Bounos C; Simopoulou T; Fragoulis GE; Panopoulos S; Fragiadaki K; Evangelatos G; Bournia VK; Arida A; Karamanakos A; Pappa M; Kravvariti E; Deftereou K; Kougkas N; Zampeli E; Kataxaki E; Melissaropoulos K; Barouta G; Panagiotopoulos A; Koutsianas C; Liossis SN; Georgiou P; Dimitroulas T; Tektonidou MG; Bogdanos DP; Elezoglou A; Voulgari PV; Sfikakis PP; Vassilopoulos D
Clin Rheumatol; 2023 Dec; 42(12):3375-3385. PubMed ID: 37731083
[TBL] [Abstract][Full Text] [Related]
14. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa.
Jassat W; Abdool Karim SS; Ozougwu L; Welch R; Mudara C; Masha M; Rousseau P; Wolmarans M; Selikow A; Govender N; Walaza S; von Gottberg A; Wolter N; Terrence Pisa P; Sanne I; Govender S; Blumberg L; Cohen C; Groome MJ;
Clin Infect Dis; 2023 Apr; 76(8):1468-1475. PubMed ID: 36453094
[TBL] [Abstract][Full Text] [Related]
15. In-hospital mortality of older patients with COVID-19 throughout the epidemic waves in the great Paris area: a multicenter cohort study.
Thietart S; Rozes A; Tubach F; Marot S; Marcelin AG; Raux M; Vallet H; Riou B; Boddaert J; Zerah L
BMC Geriatr; 2023 Sep; 23(1):573. PubMed ID: 37723419
[TBL] [Abstract][Full Text] [Related]
16. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
[TBL] [Abstract][Full Text] [Related]
18. Pre-Delta, Delta, and Omicron Periods of the Coronavirus Disease 2019 (COVID-19) Pandemic and Health Outcomes During Delivery Hospitalization.
Carlson J; Simeone RM; Ellington S; Galang R; DeSisto CL; Fleming-Dutra K; Riley L; Meaney-Delman D; Tong VT
Obstet Gynecol; 2024 Jan; 143(1):131-138. PubMed ID: 37917932
[TBL] [Abstract][Full Text] [Related]
19. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.
Wang C; Liu B; Zhang S; Huang N; Zhao T; Lu QB; Cui F
J Med Virol; 2023 Jan; 95(1):e28118. PubMed ID: 36056540
[TBL] [Abstract][Full Text] [Related]
20. Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.
Ward IL; Bermingham C; Ayoubkhani D; Gethings OJ; Pouwels KB; Yates T; Khunti K; Hippisley-Cox J; Banerjee A; Walker AS; Nafilyan V
BMJ; 2022 Aug; 378():e070695. PubMed ID: 35918098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
